午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> CAS DataBase List >>formycin diphosphate

formycin diphosphate

CAS No.
18389-49-6
Chemical Name:
formycin diphosphate
Synonyms
formycin diphosphate;(S)-1-C-(7-Amino-1H-pyrazolo(4,3-D)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(trihydrogen diphosphate);D-Ribitol, 1-C-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-, 5-(trihydrogen diphosphate), (1S)-;D-Ribitol, 1-C-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-, 5-(trihydrogen diphosphate), (1S)- (9CI)
CBNumber:
CB01341526
Molecular Formula:
C10H15N5O10P2
Molecular Weight:
427.2
MDL Number:
MOL File:
Mol file
Last updated:2023-05-04 17:34:35

formycin diphosphate Properties

Boiling point 905.7±75.0 °C(Predicted)
Density 2.064±0.06 g/cm3(Predicted)
pka 1.39±0.10(Predicted)

formycin diphosphate Chemical Properties,Uses,Production

Definition

ChEBI: ADP is a purine ribonucleoside 5'-diphosphate having adenine as the nucleobase. It has a role as a human metabolite and a fundamental metabolite. It is an adenosine 5'-phosphate and a purine ribonucleoside 5'-diphosphate. It is a conjugate acid of an ADP(3-) and an ADP(2-).

formycin diphosphate Preparation Products And Raw materials

Raw materials

Preparation Products

formycin diphosphate (S)-1-C-(7-Amino-1H-pyrazolo(4,3-D)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(trihydrogen diphosphate) D-Ribitol, 1-C-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-, 5-(trihydrogen diphosphate), (1S)- (9CI) D-Ribitol, 1-C-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-, 5-(trihydrogen diphosphate), (1S)- 18389-49-6
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept